Table 2.
Recommended dose of remdesivir based on the U.S. Food and Drug Administration formulation [45]
Weight (kg) | Require invasive mechanical ventilation and/or ECMO | Dosage | Formulation | Duration |
|||
---|---|---|---|---|---|---|---|
Day | Infusion bag volumeb) | Infusion time (min) | Rate infusion (mL/min) | ||||
3.5–40 | No | 5 mg/kg IV (single dose) | Remdesivir for injection, 100 mg, lyophilized powder only (Reconstitute with 19 mL of Sterile Water for Injection and dilute in 0.9% saline prior to administration) | Day 1 | 100 mL | 30 | 3.33 |
60 | 1.67 | ||||||
2.5 mg/kg IV (single dose) | Days 2–5a) | 120 | 0.83 | ||||
50 mL | 30 | 1.67 | |||||
3.5–40 | Yes | 5 mg/kg IV (single dose) | Day 1 | 60 | 0.83 | ||
120 | 0.42 | ||||||
2.5 mg/kg IV (single dose) | Days 2–10 | 25 mL | 30 | 0.83 | |||
60 | 0.42 | ||||||
120 | 0.21 | ||||||
≥40 | No | 200 mg IV (single dose) | Remdesivir injection (Dilute remdesivir injection concentrated solution in 0.9% saline prior to administration) or remdesivir for injection | Day 1 | 250 mL | 30 | 8.33 |
60 | 4.17 | ||||||
100 mg IV (single dose) | Days 2–5a) | 120 | 2.08 | ||||
≥40 | Yes | 200 mg IV (single dose) | Day 1 | 100 mL | 30 | 3.33 | |
60 | 1.67 | ||||||
100 mg IV (single dose) | Days 2–10 | 120 | 0.83 |
ECMO, extracorporeal membrane oxygenation; IV, intravenous.
May be extended up to 5 extra days if no clinical improvement is seen.
The total volume in several options of infusion bag packages.